Vital Therapies (VTL) Announces Stockholder Approval of Business Combination with Immunic AG

April 4, 2019 4:09 PM EDT Send to a Friend
Vital Therapies, Inc. (Nasdaq: VTL) announced that its stockholders voted to approve the proposals required to complete the business ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login